Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
The Journal of Infectious Diseases2013Vol. 208(3), pp. 418–422
Citations Over TimeTop 10% of 2013 papers
Julie E. Ledgerwood, Kathryn L. Zephir, Zonghui Hu, Chih‐Jen Wei, Lee-Jah Chang, Mary E. Enama, Cynthia S. Hendel, Sandra Sitar, Robert T. Bailer, Richard A. Koup, John R. Mascola, Gary J. Nabel, Barney S. Graham, the VRC 310 Study Team
Abstract
H5 DNA priming enhances antibody responses after an MIV boost when the prime-boost interval is 12-24 weeks. Clinical Trials Registration. NCT01086657.
Related Papers
- → Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months(2021)31 cited
- → Genetic Analysis of Primary and Secondary Immune Responses in the Chicken(1983)76 cited
- → Changes in skin-sensitizing antibody titer after injections of aqueous pollen extract(1969)33 cited
- → Anti-Human Growth Hormone (HGH) Antibody Determination in HGH-treated Patients(1978)2 cited
- The dynamic change of chicken serum antibody after inject IgY(2012)